Syngene International, a global contract research, development, and manufacturing organisation (CRDMO), announced site upgrades to accelerate drug discovery and development, helping clients bring novel therapies to market faster.
CN Bio, a provider of benchtop Organ-on-a-chip (OOC) solutions that accelerate drug discovery and development, today announced the launch of PhysioMimix Core.
SteriPack, a global contract design and manufacturing organisation (CDMO) for the pharmaceutical and medical device industries, has announced its trading name change to Ensera, signalling a strategic shift in its identity and service offering.
Cold Chain Technologies (CCT) has played a role in demonstrating the viability of ocean freight for high value temperature sensitive pharmaceutical shipments, through a project with logistics companies Kuehne + Nagel and Teva Pharmaceuticals.
On 10th November at 9:00 AM - 9:30 AM CT, Sarang Oka, scientific fellow, Hovione, will do a talk titled "Addressing Practical Challenges in CM via Novel Hardware and Automation" at PharmSci360 in San Antonio, TX.
Orbia Fluor & Energy Materials (Orbia), has announced it has supplied its first large-scale delivery of its new low global warming potential (low-GWP) medical propellant, Zephex 152a.
ACD/Labs, an informatics company that develops and commercialises software in support of R&D, and Covestro have joined forces to bring AI-powered solvent recommendation capabilities to the Percepta platform.
Boyds’ chief development officer, Dr Nick Meyers, and director of regulatory affairs, Dr Eric Hardter, provide advice and guidance to drug developers and sponsors on de-risking the Investigational New Drug (IND) process.
Guardtech Group will be presenting the latest developments in cleanroom construction at Lab Innovations, taking place at the NEC in Birmingham on 29–30th October.
NNIT has announced that its European division has secured another project with a long-term strategic partner to support the implementation of a solution from a provider of digital solutions for the life sciences industry.
